To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment Subjects
Clinical trial NCT06522945 · COMPLETED
Trial details
- NCT number
- NCT06522945
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-24
- Primary completion
- 2025-12-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.